BIOLAB FARMA
PRODUCT
RENEHAVIS INTRA-ARTICULAR LMW 15.4MG 1 SYRINGE
BRIEF DESCRIPTION/INDICATION
RenehaVis® is indicated for viscosupplementation to improve synovial rheological properties, relieving joint pain and stiffness in patients with osteoarthritis of the knee.
PRESENTATION
Intra-articular solution 15.4 mg/0.7 mL (LMW), 7.0 mg/0.7 mL (HMW)
THERAPEUTIC CLASS
M05X0 - T.O.FAR.ACCA MUSC-ESQUE
CLASSIFICATION
Exempt from prescription
COMPOSITE
Sodium hyaluronate
IF SYMPTOMS PERSIST, THE DOCTOR SHOULD BE CONSULTED.